Stock Events

Biolife Solutions 

$23.79
14
-$0.94-3.8% Friday 20:00

Statistics

Day High
24.8
Day Low
23.12
52W High
26.73
52W Low
8.92
Volume
358,356
Avg. Volume
345,266
Mkt Cap
1.19B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-0.38
-0.28
-0.18
-0.08
Expected EPS
-0.076
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLFS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Brown & Brown
BRO
Mkt Cap29.99B
Brooks Automation provides automated cold storage solutions and services, competing in the biostorage sector with BioLife.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific offers a broad range of products for the bioprocessing and preservation sectors, overlapping with BioLife's offerings.
Becton Dickinson
BDX
Mkt Cap70.07B
Becton, Dickinson and Company offers products and services in the biosciences field, including cell therapy solutions that compete with BioLife's products.
Danaher
DHR
Mkt Cap194.5B
Danaher Corporation's life sciences division offers products and services that compete in the bioprocessing and preservation space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen provides sample and assay technologies for molecular diagnostics, applying preservation technologies that can compete with BioLife's solutions.
Illumina
ILMN
Mkt Cap20.93B
Illumina offers genomic sequencing solutions that require high-quality preservation of samples, indirectly competing with BioLife's preservation media.
Pacific Biosciences of California
PACB
Mkt Cap373.36M
Pacific Biosciences provides genomic analysis systems that also necessitate high-quality sample preservation, competing in the broader biopreservation market.
Agenus
AGEN
Mkt Cap111.1M
Agenus is involved in the discovery and development of immunotherapies, which requires the preservation of biological samples, indirectly competing with BioLife.
Novavax
NVAX
Mkt Cap1.98B
Novavax, a vaccine development company, requires stringent biopreservation for its products, making it a competitor in the biopreservation market.

Analyst Ratings

26.2$Average Price Target
The highest estimate is $30.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Show more...
CEO
Michael Rice
Employees
409
Country
US
ISIN
US09062W2044

Listings